|
 |
Scientific Advisory Board |
|
William D Kingsbury
PhD
 William D Kingsbury, PhD, Medicinal Chemistry Independent Consultant, received a PhD in Organic Chemistry from Wayne State University, Detroit, Michigan, and completed postdoctoral training in Medicinal Chemistry at the University of Kansas, Lawrence. Dr. Kingsbury recently completed a distinguished career in the Department of Medicinal Chemistry at GlaxoSmithKline Pharmaceuticals (formerly SK&F Laboratories and SB Pharmaceuticals), where he held a number of leadership positions, retiring as a Director in 2006.
Among Dr Kingsbury’s many accomplishments is the synthesis of topotecan (HycamtinTM), a DNA topoisomerase I inhibitor that is now marketed for treatment of ovarian, lung, and other cancers. Dr Kingsbury is an author of numerous publications and holds 15 chemical patents
|
|
Our Mission
